Clinical Trial Result Marks a Significant Accomplishment for Medicortex Finland

Adrian Harel (adrian.harel a, May 2nd 2017

We have now analyzed the results of our first clinical trial. They demonstrate the diagnostic potential of the new biomarker test in humans with brain injury and they confirm the findings we had in our preclinical studies. This is a significant proof-of-concept and it represents a remarkable milestone for Medicortex.

Please see the Press Release. 

Suomeksi / In Finnish: Kliinisen kokeen tulokset merkittävä saavutus Medicortexille